AI Stock Memo: HQY - HealthEquity - RankAlpha

HQY

AI MemoPost-earnings T+3

HealthEquity

As of 2026-05-29/Post-earnings T+3/Confidence medium

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-05-29 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Action

—

Confidence

medium

Horizon

—

Key catalyst

Q1 beat and FY2027 guide raise • 2026-05-29

Expected move: +30%

Biggest risk

Forward growth is still modest relative to valuation expectations, and the company remains exposed to HSA/tax-policy changes, cyber/partner risk, and leverage (about $942.7M of long-term debt) [#8-K-2026-05-28][#10-Q-2026-05-28].

Invalidation

Break below $79 or thesis failure.

What would change my mind?

The beat-and-raise print showed 46% Adjusted EBITDA margin, 19% HSA asset growth, and a larger buyback program, reinforcing a durable operating-leverage story [#8-K-2026-05-28].

Research note

Recommendation

—

Confidence

medium

As of

2026-05-29

Base target

$114

p=50%

Bull target

$130

p=30%

Bear target

$79

p=20%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

Post-print tape stays constructive
HSA assets and accounts keep compounding
The beat-and-raise print showed 46% Adjusted EBITDA margin, 19% HSA asset growth, and a larger buyback program, reinforcing a durable operating-leverage story [#8-K-2026-05-28].

BearKey bullets

Changes to HSA tax treatment, healthcare regulation, or CDB adoption could weaken the structural growth story [#8-K-2026-05-28].
Cybersecurity, systems uptime, fraud, or third-party custodial/insurance partner issues could directly hit reputation and results [#8-K-2026-05-28].
Long-term debt was about $942.7M at April 30, 2026, so leverage and capital-allocation discipline still matter [#10-Q-2026-05-28].

WatchKey bullets

Q1 beat and FY2027 guide raise

Summary

High-level snapshot

Recommendation

Model confidence

medium

Timeframe

Asset

Equity

Trigger

Post-earnings T+3

Base case: $114 (p=50%)

Bull/Bear spread: +48% / -10%

Vs latest close: Bull +48% · Base +30% · Bear -10%

Scenario probabilities

Bull Target: $130 (p=30%)Base Target: $114 (p=50%)Bear Target: $79 (p=20%)

Commentary

Post-earnings tone is positive because the company beat estimates, raised FY2027 guidance, and the shares rose 3.9% after hours; however, the checked sources did not yet show a clear post-print analyst revision wave, so this remains a monitoring view rather than a fully confirmed re-rate.

As of 2026-05-29 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

The beat-and-raise print showed 46% Adjusted EBITDA margin, 19% HSA asset growth, and a larger buyback program, reinforcing a durable operating-leverage story [#8-K-2026-05-28].

Bear Case

Drivers

Scannable catalysts and supporting factors

Post-print tape stays constructive
HSA assets and accounts keep compounding

Scenarios

Bull Target (Scenario probability)

$130 / p=30% prob

Base Target (Scenario probability)

$114 / p=50% prob

Bear Target (Scenario probability)

$79 / p=20% prob

Price $88 as of 2026-05-29

Nearest Scenario: Bear (∆ 10%)

Targets vs latest close: Bull +48% · Base +30% · Bear -10%

Sentiment & Exposure

News Sentiment (30d)

0.65

Social Sentiment (7d)

0.00

Events

Other notable items detected

EVENT2026-05-29
Q1 beat and FY2027 guide raise
HealthEquity reported Q1 revenue of $354.6M and non-GAAP EPS of $1.24 versus $1.11 consensus, then raised FY2027 revenue guidance to $1.410B-$1.420B and Adjusted EBITDA to $625M-$633M while authorizing an additional $1.0B of repurchases [#8-K-2026-05-28].
Prob 85.00% • Move 4.00% • Priced-in 70.00%

Short-term Catalysts

Next few weeks

Post-print tape stays constructive
2026-05-29
Trusted market coverage said the shares were up 3.9% in after-hours trading after the beat-and-raise print, but the post-earnings analyst revision set was still thin in the sources checked.
Prob 65% • Move 3% • Priced-in 75%

Long-term Catalysts

Months to a year

HSA assets and accounts keep compounding
2026-08-31
HSAs reached 10.6M (+8% y/y) and total HSA assets reached $37.1B (+19% y/y), supporting a longer-run operating leverage case as the member base deepens and the asset mix shifts toward investments [#8-K-2026-05-28].
Prob 60% • Move 8% • Priced-in 55%

Risks

Changes to HSA tax treatment, healthcare regulation, or CDB adoption could weaken the structural growth story [#8-K-2026-05-28].
Cybersecurity, systems uptime, fraud, or third-party custodial/insurance partner issues could directly hit reputation and results [#8-K-2026-05-28].
Long-term debt was about $942.7M at April 30, 2026, so leverage and capital-allocation discipline still matter [#10-Q-2026-05-28].
Revenue growth remains mid-single-digit despite strong margin expansion, so multiple expansion depends on continued operating leverage [#8-K-2026-05-28].

Peers

Symbol	Summary
CHE	Same broad health-care services sector and closer market-cap band, but it is not an HSA custodian, so it is only a loose operating comp.
HSIC	Healthcare distribution/services peer with similar scale, but the business mix is much less directly tied to HSA asset growth and custodial revenue.
GKOS	Similar market-cap/sector peer, but ophthalmic device exposure makes it a weak fundamental comp for HealthEquity's consumer-directed benefits model.

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment Codex
Human targets: serper
Analysis date: 2026-05-29